ELTX Elicio Therapeutics, Inc. - Common Stock
$3,06
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 13, 2026
52W-Spanne
$3–$16
3% of range
Analystenbewertung
BUY
10 analysts
Kursziel
$20
+554% upside
P/E (TTM)
-3.1
ROE
—
Nettogewinnmarge
—
ELTX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$3.06
Marktkapitalisierung
—
P/E (TTM)
-3.1
EPS (TTM)
$-2.58
Umsatz (TTM)
—
Dividendenrendite
—
ROE
—
Verschuldungsgrad
—
52W-Spanne
$3 – $16
ELTX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
2020-12-31
→
2022-12-31
EPS
$-2.58
2020-12-31
→
2025-12-31
Freier Cashflow
—
2021-12-31
→
2024-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ELTX
Peer-Median
P/E (TTM)
-3.1
4.7
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ELTX
Peer-Median
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ELTX
Peer-Median
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ELTX
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ELTX
Peer-Median
ELTX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
10 Analysten
- Starker Kauf 3 30,0%
- Kauf 5 50,0%
- Halten 2 20,0%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
3 Analysten · 2026-08-15
Median
$23.00
Mittelwert
$20.00
← Unter allen Zielen
$3.06
Tief
$10.00
Hoch
$27.00
Median-Ziel
$23.00
+651,6%
Mittelwert-Ziel
$20.00
+553,6%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.04%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.65 | $-0.47 | -0.18% |
| 31. Dezember 2025 | $-0.45 | $-0.45 | 0.00% |
| 30. September 2025 | $-0.60 | $-0.56 | -0.04% |
| 30. Juni 2025 | $-0.66 | $-0.70 | 0.04% |
| 31. März 2025 | $-0.87 | $-0.85 | -0.02% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ELTX | — | -3.1 | — | — | — | — |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | — |
| ICCC | — | -51.2 | 4.3% | — | — | — |
| GANX | $135M | -5.3 | -60.6% | — | -181.1% | — |
| ACET | — | -0.5 | — | — | — | — |
| SERA | — | -4.4 | 5.2% | -39417.3% | -39.0% | — |
| ANVS | $94M | -2.5 | — | — | -164.0% | — |
| FRMM | — | — | — | -6881.3% | -368.1% | — |
| DWTX | $124M | -0.6 | 123.6% | — | -83.8% | — |
| GOSS | $724M | -4.1 | -57.7% | -351.5% | 201.8% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $2M | $28M | $3M | |
| Cost of Revenue | · | · | · | $0 | $433.0K | $1M | |
| R&D Expense | $25M | $34M | $24M | $18M | $49M | $39M | |
| SG&A Expense | $13M | $11M | $12M | $6M | $18M | $18M | |
| Operating Expenses | $38M | $45M | $36M | $24M | $68M | $58M | |
| Operating Income | $-38M | $-45M | $-36M | $-24M | $-39M | $-55M | |
| Interest Expense | · | · | $1M | $4M | · | · | |
| Other Non-op | $-2M | $-7M | $550.0K | $-4M | $-15M | $-25M | |
| Pretax Income | $-40M | $-52M | · | $-39M | $-55M | $-80M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-40M | $-52M | $-35M | $-28M | $-55M | $-80M | |
| EPS (Basic) | $-2.58 | $-4.25 | $-6.96 | $-89.27 | $-1.93 | $-5.43 | |
| EPS (Diluted) | $-2.58 | $-4.25 | $-6.96 | $-89.27 | $-1.93 | $-5.43 | |
| Shares (Basic) | 15,312,751 | 12,202,996 | 5,056,225 | 315,998 | 28,244,825 | 14,762,120 | |
| Shares (Diluted) | 15,312,751 | 12,202,996 | 5,056,225 | 315,998 | 28,244,825 | 14,762,120 | |
| EBITDA | · | $-45M | · | · | $-39M | · |
Bilanz 26
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $18M | $13M | $6M | $89M | $35M | |
| Receivables | · | · | · | $0 | · | · | |
| Prepaid Expense | $748.0K | $2M | $3M | $3M | $2M | $8M | |
| Other Current Assets | · | · | · | $246.0K | $498.0K | $360.0K | |
| Current Assets | $19M | $21M | $16M | $11M | $91M | $42M | |
| PP&E (Net) | $295.0K | $483.0K | $717.0K | $1M | $451.0K | $156.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $968.0K | $582.0K | |
| Accum. Depreciation | $2M | $2M | $1M | $1M | $517.0K | $426.0K | |
| Other Non-current Assets | · | · | · | $61.0K | $106.0K | $0 | |
| Total Assets | $26M | $28M | $27M | $23M | $97M | $47M | |
| Accounts Payable | $672.0K | $1M | $4M | $3M | $5M | $6M | |
| Accrued Liabilities | $6M | $8M | $4M | $2M | $3M | $7M | |
| Current Liabilities | $8M | $12M | $10M | $7M | $11M | $107M | |
| Capital Leases | $4M | $5M | $6M | $7M | $3M | $4M | |
| Other Non-current Liabilities | · | · | · | · | $0 | · | |
| Total Liabilities | $24M | $39M | $16M | $14M | $15M | $138M | |
| Long-term Debt | $10M | · | · | · | · | · | |
| Total Debt | · | · | · | · | $0 | · | |
| Common Stock | $178.0K | $110.0K | $96.0K | $3.0K | $300.0K | $156.0K | |
| Paid-in Capital | $235M | $183M | $154M | $5M | $296M | $72M | |
| Retained Earnings | $-234M | $-194M | $-142M | $-107M | $-215M | $-161M | |
| Treasury Stock | $150.0K | $150.0K | $150.0K | $0 | $0 | $2M | |
| AOCI | $-127.0K | $-175.0K | $-197.0K | $0 | $-103.0K | $-333.0K | |
| Stockholders' Equity | $2M | $-11M | $11M | $-102M | $-75M | $-90M | |
| Liabilities + Equity | $26M | $28M | $27M | $23M | $97M | $47M | |
| Shares Outstanding | 17,800,307 | 11,043,837 | 9,618,178 | 320,281 | 310,200 | 15,632,809 |
Cashflow 11
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $1M | $1M | $579.0K | $12M | $5M | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | |
| Restructuring | · | · | · | $9M | · | · | |
| Operating Cash Flow | $-37M | $-37M | $-33M | $-22M | $-53M | $-23M | |
| CapEx | $16.0K | $87.0K | $66.0K | $654.0K | $382.0K | $41.0K | |
| Investing Cash Flow | $-16.0K | $-84.0K | $-32.0K | $-654.0K | $-382.0K | $-41.0K | |
| Stock Issued | $16M | $5M | $7M | · | $107M | $-522.0K | |
| Net Stock Activity | · | $5M | · | · | $107M | · | |
| Financing Cash Flow | $37M | $42M | $39M | $21M | $107M | $52M | |
| Net Change in Cash | $-225.0K | $5M | $6M | $-2M | $54M | $29M | |
| Free Cash Flow | · | $-37M | · | · | $-53M | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -138.8% | · | |
| Net Margin | · | · | · | · | -192.8% | · | |
| Pretax Margin | · | · | · | · | -192.8% | · | |
| EBITDA Margin | · | · | · | · | -138.8% | · | |
| ROA | · | -187.6% | · | · | -75.9% | · | |
| ROE | · | 342.6% | · | · | -74.8% | · | |
| ROIC | · | · | · | · | -48.2% | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | · | 1.8 | · | · | 8.1 | · | |
| Quick Ratio | · | 1.5 | · | · | 7.9 | · | |
| Debt / Equity | · | · | · | · | 0.0 | · | |
| LT Debt / Equity | · | · | · | · | 0.0 | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.4 | · |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -91.9% | 883.1% | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $2M | $2M | $28M | $3M | |
| Net Income TTM | $-40M | $-52M | $-35M | $-28M | $-55M | $-80M | |
| Market Cap | · | $56M | · | · | $869M | · | |
| Enterprise Value | · | · | · | · | $780M | · | |
| P/E | -3.1 | -1.2 | -1.2 | -0.1 | -15.0 | · | |
| P/S | · | 24.4 | · | · | 30.7 | · | |
| P/B | · | -5.0 | · | · | 10.7 | · | |
| P / Tangible Book | 86.6 | · | 7.0 | · | · | · | |
| P / Cash Flow | · | -1.5 | · | · | -16.5 | · | |
| P / FCF | · | -1.5 | · | · | -16.4 | · | |
| EV / EBITDA | · | · | · | · | -19.8 | · | |
| EV / FCF | · | · | · | · | -14.7 | · | |
| EV / Revenue | · | · | · | · | 27.6 | · | |
| Earnings Yield | -32.4% | -83.3% | -83.5% | -1099.4% | -6.7% | · |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | $0 | |
| R&D Expense | $7M | $7M | $5M | $5M | $7M | $8M | $11M | $7M | $8M | $8M | $6M | $7M | $5M | $5M | $-3M | $5M | |
| SG&A Expense | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $2M | $-1M | $1M | |
| Operating Expenses | $10M | $11M | $9M | $8M | $10M | $11M | $13M | $10M | $11M | $10M | $9M | $11M | $8M | $8M | $-4M | $6M | |
| Operating Income | $-10M | $-11M | $-9M | $-8M | $-10M | $-11M | $-13M | $-10M | $-11M | $-10M | $-9M | $-11M | $-8M | $-8M | $3M | $-6M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $36.0K | · | $1.0K | $714.0K | $342.0K | $92.0K | $1M | |
| Interest Income | $138.0K | $157.0K | · | $199.0K | $168.0K | $210.0K | · | $185.0K | $137.0K | · | · | $246.0K | $39.0K | · | · | · | |
| Other Non-op | $2M | $-1M | $1M | $-2M | $-470.0K | $-473.0K | $-527.0K | $-8M | $4M | $-2M | $443.0K | $113.0K | $218.0K | $-224.0K | $-2M | $-1M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-8M | $-12M | $-8M | $-10M | $-11M | $-11M | $-14M | $-19M | $-7M | $-12M | $-9M | $-11M | $-8M | $-8M | $-7M | $-7M | |
| EPS (Basic) | $-0.43 | $-0.65 | $-0.45 | $-0.60 | $-0.66 | $-0.87 | $-1.07 | $-1.39 | $-0.64 | $-1.15 | $21.69 | $-1.27 | $-2.61 | $-24.77 | $-42.92 | $-22.67 | |
| EPS (Diluted) | $-0.43 | $-0.65 | $-0.45 | $-0.60 | $-0.66 | $-0.87 | $-1.07 | $-1.39 | $-0.64 | $-1.15 | $21.69 | $-1.27 | $-2.61 | $-24.77 | $-42.92 | $-22.67 | |
| Shares (Basic) | 19,244,679 | 18,211,745 | -30,389,722 | 16,692,476 | 16,059,423 | 12,950,574 | -22,938,127 | 13,582,345 | 11,284,853 | 10,273,925 | -6,537,509 | 8,376,384 | 2,893,244 | 324,106 | -30,275,337 | 317,512 | |
| Shares (Diluted) | 19,244,679 | 18,211,745 | -30,389,722 | 16,692,476 | 16,059,423 | 12,950,574 | -22,938,127 | 13,582,345 | 11,284,853 | 10,273,925 | -6,537,509 | 8,376,384 | 2,893,244 | 324,106 | -30,275,337 | 317,512 | |
| EBITDA | $-10M | $-11M | · | $-8M | $-10M | $-11M | · | $-10M | $-11M | $-10M | · | $-11M | $-8M | $-5M | · | $-9M |
Bilanz 25
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23M | $15M | $19M | $21M | $22M | $18M | $18M | $26M | $3M | $12M | $13M | $15M | $22M | $29M | $6M | $55M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | $10M | · | · | |
| Prepaid Expense | $2M | $1M | $748.0K | $854.0K | $510.0K | $2M | $2M | $3M | $3M | $2M | $3M | $3M | $5M | $2M | $3M | $2M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | $405.0K | · | $326.0K | |
| Current Assets | $25M | $16M | $19M | $21M | $23M | $21M | $21M | $31M | $7M | $14M | $16M | $20M | $26M | $41M | $11M | $57M | |
| PP&E (Net) | $213.0K | $249.0K | $295.0K | $328.0K | $377.0K | $430.0K | $483.0K | $523.0K | $597.0K | $635.0K | $717.0K | $772.0K | $919.0K | $0 | $1M | $304.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $0 | $2M | $968.0K | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $0 | $1M | $664.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | $864.0K | · | $75.0K | |
| Total Assets | $31M | $23M | $26M | $28M | $30M | $28M | $28M | $38M | $16M | $24M | $27M | $31M | $38M | $42M | $23M | $61M | |
| Accounts Payable | $839.0K | $272.0K | $672.0K | $321.0K | $4M | $4M | $1M | $2M | $1M | $1M | $4M | $4M | $4M | $692.0K | $3M | $2M | |
| Accrued Liabilities | $7M | $6M | $6M | $5M | $5M | $6M | $8M | $5M | $5M | $3M | $4M | $4M | $2M | $1M | $2M | $5M | |
| Current Liabilities | $9M | $7M | $8M | $7M | $10M | $11M | $12M | $9M | $8M | $6M | $10M | $11M | $8M | $2M | $7M | $8M | |
| Capital Leases | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $6M | $70.0K | $7M | $3M | |
| Total Liabilities | $23M | $24M | $24M | $24M | $28M | $19M | $39M | $57M | $17M | $20M | $16M | $18M | $14M | $2M | $14M | $11M | |
| Long-term Debt | · | · | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $10M | $9M | · | $10M | $9M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $219.0K | $186.0K | $178.0K | $173.0K | $163.0K | $160.0K | $110.0K | $108.0K | $103.0K | $102.0K | $96.0K | $84.0K | $84.0K | $301.0K | $3.0K | $301.0K | |
| Paid-in Capital | $262M | $244M | $235M | $230M | $218M | $214M | $183M | $161M | $160M | $159M | $154M | $147M | $146M | $298M | $5M | $297M | |
| Retained Earnings | $-254M | $-245M | $-234M | $-226M | $-216M | $-205M | $-194M | $-180M | $-161M | $-154M | $-142M | $-133M | $-123M | $-258M | $-107M | $-248M | |
| Treasury Stock | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | · | $0 | · | |
| AOCI | $-126.0K | $-122.0K | $-127.0K | $-31.0K | $-70.0K | $-144.0K | $-175.0K | $-202.0K | $-238.0K | $-270.0K | $-197.0K | $-25.0K | $-2.0K | $165.0K | $0 | $302.0K | |
| Stockholders' Equity | $8M | $-1M | $2M | $4M | $2M | $9M | $-11M | $-19M | $-2M | $5M | $11M | $13M | $24M | $40M | $-102M | $50M | |
| Liabilities + Equity | $31M | $23M | $26M | $28M | $30M | $28M | $28M | $38M | $16M | $24M | $27M | $31M | $38M | $42M | $23M | $61M | |
| Shares Outstanding | 21,901,569 | 18,639,895 | 17,800,307 | 17,258,652 | 16,262,932 | 15,968,736 | 11,029,382 | 10,784,377 | 10,258,873 | 10,219,989 | 9,603,723 | 8,378,361 | 8,370,268 | 30,114,190 | 320,281 | 30,113,582 |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $935.0K | $868.0K | $772.0K | $698.0K | $710.0K | $517.0K | $464.0K | $314.0K | $350.0K | $324.0K | $337.0K | $339.0K | $151.0K | $224.0K | $199.0K | $-1M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Operating Cash Flow | $-8M | $-12M | $-7M | $-11M | $-9M | $-10M | $-9M | $-7M | $-9M | $-12M | $-10M | $-5M | $-10M | $-8M | $-7M | $11M | |
| CapEx | · | · | $16.0K | $0 | · | · | $45.0K | $0 | $42.0K | $0 | $0 | $45.0K | $4.0K | $17.0K | $95.0K | $559.0K | |
| Investing Cash Flow | · | · | $-16.0K | $0 | $0 | $0 | $-45.0K | $0 | $-42.0K | $3.0K | $0 | $-45.0K | $10M | $-17.0K | $-95.0K | $-559.0K | |
| Stock Issued | · | · | · | · | $2M | $835.0K | $-858.0K | $48.0K | $303.0K | $5M | $7M | $0 | $0 | $0 | · | $0 | |
| Net Stock Activity | · | · | · | · | · | $835.0K | · | · | · | $5M | · | · | · | · | · | · | |
| Financing Cash Flow | $17M | $8M | $5M | $10M | $12M | $10M | $227.0K | $31M | $316.0K | $11M | $7M | $60.0K | $35M | $10M | $11M | $10M | |
| Net Change in Cash | $8M | $-4M | $-2M | $-1M | $3M | $240.0K | $-9M | $24M | $-9M | $-1M | $-3M | $-5M | $35M | $2M | $4M | $20M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-12M | · | · | · | · | · | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -27.0% | -46.5% | · | -30.2% | -46.7% | -42.6% | · | -54.3% | -27.1% | -35.7% | · | -23.1% | -13.9% | -7.4% | · | -10.5% | |
| ROE | -168.2% | -316.7% | · | 132.9% | -11605.5% | -162.8% | · | 661.0% | -66.0% | -53.1% | · | -33.6% | -18.1% | -8.5% | · | -15.7% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 2.2 | · | 3.3 | 2.3 | 1.8 | · | 3.4 | 0.9 | 2.4 | · | 1.7 | 3.5 | 20.0 | · | 6.9 | |
| Quick Ratio | 2.6 | 2.1 | · | 3.2 | 2.2 | 1.6 | · | 2.9 | 0.5 | 2.0 | · | 1.3 | 2.9 | 19.2 | · | 6.7 | |
| Debt / Equity | 1.2 | -6.6 | · | 2.5 | 5.1 | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 1.2 | -6.6 | · | 2.5 | 5.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -284.5 | · | -10771.0 | -10.9 | · | · | · |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · |
Bewertung (TTM) 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $4M | |
| Net Income TTM | $-41M | $-44M | · | $-51M | $-48M | $-49M | · | $-49M | $-37M | $-38M | · | $-33M | $-30M | $-30M | · | $-37M | |
| Market Cap | $86M | $199M | · | $189M | $126M | $98M | · | $54M | $42M | $78M | · | $71M | $80M | $175M | · | $277M | |
| Enterprise Value | $72M | $194M | · | $178M | $113M | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.7 | -3.8 | · | -3.1 | -2.2 | -1.5 | · | -1.1 | -0.7 | -0.3 | · | -0.2 | -0.1 | -0.1 | · | -0.2 | |
| P/S | 37.2 | 86.6 | · | 82.1 | 54.6 | 42.7 | · | 23.6 | 18.3 | 33.8 | · | 30.8 | 34.6 | 75.9 | · | 73.7 | |
| P/B | 10.8 | -138.7 | · | 49.5 | 68.5 | 11.0 | · | -2.9 | -25.5 | 15.9 | · | 5.3 | 3.4 | 4.4 | · | 5.5 | |
| P / Tangible Book | 10.8 | · | · | 49.5 | 68.5 | 11.0 | · | · | · | 15.9 | · | 5.3 | 3.4 | 4.4 | · | 5.5 | |
| P / Cash Flow | · | -17.1 | · | · | · | -9.7 | · | · | · | -6.4 | · | · | · | -21.6 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -6.4 | · | · | · | · | · | · | |
| EV / EBITDA | -6.9 | -18.3 | · | -22.1 | -11.2 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 31.2 | 84.2 | · | 77.3 | 49.0 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -59.9% | -26.0% | · | -32.2% | -46.1% | -65.8% | · | -88.5% | -138.0% | -392.1% | · | -607.3% | -771.0% | -1226.2% | · | -509.6% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | — | — | — | $2M | $28M |
| Betriebsgewinnmarge % | — | — | — | — | -138.8% |
| Nettoergebnis | $-40M | $-52M | $-35M | $-28M | $-55M |
| Verwässerte EPS | $-2.58 | $-4.25 | $-6.96 | $-89.27 | $-1.93 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | — | — | — | — | 0.0 |
| Liquiditätsgrad | — | 1.8 | — | — | 8.1 |
| Quick Ratio | — | 1.5 | — | — | 7.9 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | — | $-37M | — | — | $-53M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 68 Einreicher · $21.7M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 39 (+16 vs. Vorquartal) | 22 (+15 vs. Vorquartal) | 13 (+1 vs. Vorquartal) | 7 (-2 vs. Vorquartal) | +1.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Knoll Capital Management, LLC | $4.738.751 | 1.211.957 | 21,81% | Aktien |
| VANGUARD GROUP INC | $3.369.436 | 423.296 | 15,50% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.237.110 | 572.151 | 10,29% | Aktien |
| Caption Management, LLC | $1.634.771 | 418.100 | 7,52% | Kaufoption |
| GEODE CAPITAL MANAGEMENT, LLC | $1.042.134 | 266.474 | 4,80% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $709.274 | 181.400 | 3,26% | Kaufoption |
| STATE STREET CORP | $701.532 | 179.420 | 3,23% | Aktien |
| Caption Management, LLC | $647.887 | 165.700 | 2,98% | Verkaufsoption |
| JANE STREET GROUP, LLC | $600.576 | 153.600 | 2,76% | Verkaufsoption |
| CITADEL ADVISORS LLC | $524.722 | 134.200 | 2,41% | Kaufoption |
| DIADEMA PARTNERS LP | $438.311 | 112.100 | 2,02% | Kaufoption |
| Ikarian Capital, LLC | $418.761 | 107.100 | 1,93% | Kaufoption |
| Ikarian Capital, LLC | $418.761 | 107.100 | 1,93% | Verkaufsoption |
| Ikarian Capital, LLC | $391.000 | 100.000 | 1,80% | Aktien |
| DIADEMA PARTNERS LP | $391.000 | 100.000 | 1,80% | Verkaufsoption |
| TORONTO DOMINION BANK | $391.000 | 100.000 | 1,80% | Kaufoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $352.291 | 90.100 | 1,62% | Verkaufsoption |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $347.619 | 88.905 | 1,60% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $344.322 | 88.062 | 1,58% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $317.805 | 81.280 | 1,46% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $126.684 | 32.400 | 0,58% | Kaufoption |
| BOOTHBAY FUND MANAGEMENT, LLC | $126.684 | 32.400 | 0,58% | Verkaufsoption |
| JANE STREET GROUP, LLC | $126.684 | 32.400 | 0,58% | Kaufoption |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $123.970 | 31.706 | 0,57% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $119.998 | 30.690 | 0,55% | Aktien |
| Leonteq Securities AG | $78.200 | 20.000 | 0,36% | Aktien |
| Nuveen, LLC | $69.942 | 17.888 | 0,32% | Aktien |
| CITIGROUP INC | $66.384 | 16.978 | 0,31% | Aktien |
| Bank of New York Mellon Corp | $62.099 | 15.882 | 0,29% | Aktien |
| CITADEL ADVISORS LLC | $58.650 | 15.000 | 0,27% | Verkaufsoption |
| NEW YORK STATE COMMON RETIREMENT FUND | $55.522 | 14.200 | 0,26% | Aktien |
| MEYER HANDELMAN CO | $54.345 | 13.899 | 0,25% | Aktien |
| HighTower Advisors, LLC | $53.434 | 13.666 | 0,25% | Aktien |
| DEUTSCHE BANK AG\ | $49.469 | 12.652 | 0,23% | Aktien |
| CIBC Private Wealth Group LLC | $42.560 | 7.000 | 0,20% | Aktien |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $41.663 | 11.972 | 0,19% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $41.055 | 10.500 | 0,19% | Aktien |
| HB Wealth Management, LLC | $40.910 | 10.463 | 0,19% | Aktien |
| Summit Financial, LLC | $39.120 | 10.005 | 0,18% | Aktien |
| Mayflower Financial Advisors, LLC | $39.100 | 10.000 | 0,18% | Aktien |
| MOODY LYNN LIEBERSON & WALKER, LLC | $39.100 | 10.000 | 0,18% | Aktien |
| &PARTNERS | $39.100 | 10.000 | 0,18% | Aktien |
| RHUMBLINE ADVISERS | $26.119 | 6.681 | 0,12% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $23.331 | 5.967 | 0,11% | Aktien |
| JPMORGAN CHASE & CO | $21.488 | 5.372 | 0,10% | Aktien |
| Tower Research Capital LLC (TRC) | $20.668 | 5.286 | 0,10% | Aktien |
| Persistent Asset Partners Ltd | $17.850 | 255 | 0,08% | Verkaufsoption |
| Vanguard Global Advisers, LLC | $17.267 | 4.416 | 0,08% | Aktien |
| MORGAN STANLEY | $13.505 | 3.454 | 0,06% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $12.551 | 3.210 | 0,06% | Aktien |
| BlackRock, Inc. | $10.979 | 2.808 | 0,05% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $8.102 | 2.072 | 0,04% | Aktien |
| Steward Partners Investment Advisory, LLC | $7.910 | 2.023 | 0,04% | Aktien |
| NORTHERN TRUST CORP | $7.777 | 1.989 | 0,04% | Aktien |
| BARCLAYS PLC | $6.944 | 1.776 | 0,03% | Aktien |
| Legal & General Group Plc | $5.212 | 1.333 | 0,02% | Aktien |
| Ameritas Investment Partners, Inc. | $4.598 | 1.176 | 0,02% | Aktien |
| Russell Investments Group, Ltd. | $4.039 | 1.033 | 0,02% | Aktien |
| UBS Group AG | $3.910 | 1.000 | 0,02% | Aktien |
| Farther Finance Advisors, LLC | $3.703 | 947 | 0,02% | Aktien |
| ROYAL BANK OF CANADA | $2.000 | 443 | 0,01% | Aktien |
| SBI Securities Co., Ltd. | $716 | 183 | 0,00% | Aktien |
| FMR LLC | $485 | 124 | 0,00% | Aktien |
| NATIONAL BANK OF CANADA /FI/ | $391 | 100 | 0,00% | Aktien |
| Sterling Capital Management LLC | $180 | 46 | 0,00% | Aktien |
| PRICE T ROWE ASSOCIATES INC /MD/ | $42 | 10.586 | 0,00% | Aktien |
| Persistent Asset Partners Ltd | $15 | 1 | 0,00% | Kaufoption |
| WELLS FARGO & COMPANY/MN | $4 | 1 | 0,00% | Aktien |
Unternehmensinsider 13 Insider · 5 Führungskräfte · 8 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Robert Connelly | CEO, President and Director | 16. Juli 2026 A | — | 0 | 0 | $0 |
| Brian Piekos | Chief Financial Officer | 1. Februar 2024 A | — | 0 | 0 | $0 |
| Peter Demuth | Chief Scientific Officer | 16. Juli 2026 A | — | 0 | 0 | $0 |
| Preetam Shah | Chief Strategy and Financial Officer | 16. Juli 2026 A | — | 0 | 0 | $0 |
| Christopher Haqq | Executive Vice President, Head of R&D and Chief Medical Officer | 16. Juli 2026 A | — | 0 | 0 | $0 |
| Jay Venkatesan | Direktor | 28. Juni 2024 P | — | 0 | 0 | $0 |
| Yekaterina Chudnovsky | Direktor | 28. Dezember 2023 A | — | 0 | 0 | $0 |
| Carol Gail Ashe | Direktor | 28. Dezember 2023 A | — | 0 | 0 | $0 |
| Allen Nissenson | Direktor | 28. Dezember 2023 A | — | 0 | 0 | $0 |
| Karen J Wilson | Direktor | 28. Dezember 2023 A | — | 0 | 0 | $0 |
| Julian Adams | Direktor | 28. Dezember 2023 A | — | 0 | 0 | $0 |
| Robert R Ruffolo | Direktor | 28. Dezember 2023 A | — | 0 | 0 | $0 |
| EISA-ABC LLC | 10%-Eigentümer | 31. August 2021 J | 2.740.978 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| GKCC, LLC, Yekaterina Chudnovsky | 4. Juni 2025 | 48,00% | Änderung | — | SEC |
| Yekaterina Chudnovsky, GKCC, LLC ×6 Einreichungen | 7. März 2025 | 48,10% | Änderung | — | SEC |
| Access Industries Holdings LLC, Access Industries, LLC, Access Industries Management, LLC, Clal Industries Ltd., Clal Biotechnology Industries Ltd., Len Blavatnik ×5 Einreichungen | 10. April 2024 | — | Erste Einreichung | — | SEC |
| Jay R. Venkatesan, M.D. | 14. Juni 2023 | — | Erste Einreichung | M&A / Verkauf | SEC |
| Jay R. Venkatesan | 27. April 2022 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 7 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| IWO · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWM · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWC · iShares Trust | — | — | 18. August 2026 | Täglich |